Rheumatoid Arthritis disease length
Item
ra for at least 1 year
boolean
C0003873 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Rheumatoid Arthritis Knee joint Clinical signs
Item
clear clinical signs of active ra in 1 knee joint
boolean
C0003873 (UMLS CUI [1,1])
C0022745 (UMLS CUI [1,2])
C3540840 (UMLS CUI [1,3])
Rheumatoid Arthritis Class Functional
Item
meet ara (1987) criteria for diagnosis of ra and acr (1991) criteria for ra functional classes i, ii, or iii
boolean
C0003873 (UMLS CUI [1,1])
C0456387 (UMLS CUI [1,2])
C0205245 (UMLS CUI [1,3])
Tumor necrosis factor alpha (TNF-) inhibitors Duration of therapy | Clinical Response Inadequate
Item
inadequate clinical response to a minimum of 3 months of therapy with anti-tnf-blocking agents
boolean
C3653350 (UMLS CUI [1,1])
C0444921 (UMLS CUI [1,2])
C4055223 (UMLS CUI [2,1])
C0205412 (UMLS CUI [2,2])
Disease-Modifying Antirheumatic Drugs Background | Duration of therapy Dose Stable
Item
taking background dmards for a minimum of 3 months and at stable doses for at least 28 days
boolean
C0242708 (UMLS CUI [1,1])
C1706907 (UMLS CUI [1,2])
C0444921 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Bacterial Infection Serious
Item
serious bacterial infection in last 3 months
boolean
C0004623 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Tuberculosis
Item
history of tb
boolean
C0041296 (UMLS CUI [1])
Malignant Neoplasms
Item
history of cancer within 5 years
boolean
C0006826 (UMLS CUI [1])
Bacterial Infection Latent Evidence of | Bacterial Infection Evidence of | Virus Disease Latent Evidence of | Virus Disease Evidence of
Item
evidence of latent or active bacterial or viral infection
boolean
C0004623 (UMLS CUI [1,1])
C0205275 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,3])
C0004623 (UMLS CUI [2,1])
C0332120 (UMLS CUI [2,2])
C0042769 (UMLS CUI [3,1])
C0205275 (UMLS CUI [3,2])
C0332120 (UMLS CUI [3,3])
C0042769 (UMLS CUI [4,1])
C0332120 (UMLS CUI [4,2])
intraarticular injection of corticosteroids
Item
intra-articular corticosteroids within 3 months
boolean
C2064783 (UMLS CUI [1])
Exposure to Attenuated Vaccines
Item
exposure to live vaccines
boolean
C0332157 (UMLS CUI [1,1])
C0042211 (UMLS CUI [1,2])
Exposure to abatacept | Exposure to BMS 188667
Item
exposure to ctla4ig or bms-188667
boolean
C0332157 (UMLS CUI [1,1])
C1619966 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0378942 (UMLS CUI [2,2])
Apheresis Immunoadsorption Columns | mycophenolate mofetil | leflunomide | anakinra | Cyclosporine | Etanercept | adalimumab | infliximab | Azathioprine | Oral form medicinal gold | Parenteral form medicinal gold | Penicillamine | Calcineurin inhibitor | Cyclophosphamide | Alkylating Agents
Item
treatment with immunoadsorption column(s), mycophenolate mofetil, leflunomide, anakinra, cyclosporine, etanercept, adalimumab, infliximab, azathioprine, oral or parenteral gold, d-penacillamine, calcineurin inhibitors, cyclophosphamide or other alkylating agents
boolean
C0179100 (UMLS CUI [1])
C0209368 (UMLS CUI [2])
C0063041 (UMLS CUI [3])
C0245109 (UMLS CUI [4])
C0010592 (UMLS CUI [5])
C0717758 (UMLS CUI [6])
C1122087 (UMLS CUI [7])
C0666743 (UMLS CUI [8])
C0004482 (UMLS CUI [9])
C2585247 (UMLS CUI [10])
C2585314 (UMLS CUI [11])
C0030817 (UMLS CUI [12])
C1562036 (UMLS CUI [13])
C0010583 (UMLS CUI [14])
C0002073 (UMLS CUI [15])